drugset / Trial / NCT02837575
Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA Vaccine
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this trial is to evaluate the safety and efficacy of a therapeutic DNA vaccine in adults with symptomatic herpes simplex virus type 2 (i.e., genital herpes).
Timeline
- Start
- 2016-09
- Primary completion
- 2018-04
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VCL-HB01 | Vaccine | 1 ml | Intramuscular |